𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study

✍ Scribed by Roberta Zangaglia; Claudio Pacchetti; Chiara Pasotti; Francesca Mancini; Domenico Servello; Elena Sinforiani; Silvano Cristina; Marco Sassi; Giuseppe Nappi


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
105 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

There is debate over the cognitive and behavioral effects of deep brain stimulation (DBS) of the subthalamic nucleus (STN) in advanced Parkinson's disease (PD). To evaluate these effects, we performed a prospective, naturalistic controlled, 3‐year follow‐up study. A total of 65 PD patients were enrolled, of whom 32 underwent STN‐DBS (PD‐DBS) and 33, even though eligible for this treatment, declined surgery and chose other therapeutic procedures (PD‐control). Motor and neuropsychological functions were assessed in all the subjects at baseline (T0) and 36 months (T36). The PD‐DBS patients were also evaluated at 1, 6, 12, and 24 months after surgery (T1, T6, T12, and T24). At T1, compared with T0, the PD‐DBS patients recorded worse logical executive function task and verbal fluency (FAS) scores, whereas their performance of memory tasks remained stable. At T12, their cognitive profile had returned within the pre‐DBS range, thereafter remaining stable until T36. FAS scores at T36 were significantly worse in the PD‐DBS compared with the PD‐control patients. This is the first long‐term naturalistic controlled study of cognitive functions in PD patients submitted to STN‐DBS. Our results confirm previous reports of a worsening of verbal fluency after DBS, but show that STN‐DBS seems to be relatively safe from a cognitive standpoint, as the short‐term worsening of frontal‐executive functions was found to be transient. © 2009 Movement Disorder Society


📜 SIMILAR VOLUMES


Two-year follow-up of subthalamic deep b
✍ Jan Herzog; Jens Volkmann; Paul Krack; Florian Kopper; Monika Pötter; Delia Lore 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

## Abstract We studied 48 patients after bilateral subthalamic nucleus deep brain stimulation (STN‐DBS) who were evaluated 6 months after the surgical procedure using the Unified Parkinson's Disease Rating Scale (UPDRS) in a standardized levodopa test. Additional follow‐up was available in 32 patie

Deep brain stimulation for Parkinson's d
✍ Taresa Stefurak; David Mikulis; Helen Mayberg; Anthony E. Lang; Stephanie Heveno 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

## Abstract Behavioral disturbances have been reported with subthalamic (STN) deep brain stimulation (DBS) treatment in Parkinson's disease (PD). We report correlative functional imaging (fMRI) of mood and motor responses induced by successive right and left DBS. A 36‐year‐old woman with medically

Effects of unilateral subthalamic and pa
✍ Ken Nakamura; Chadwick W. Christine; Philip A. Starr; William J. Marks Jr. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract Deep brain stimulation (DBS) is an effective treatment for selected patients with disabling Parkinson's disease (PD). The two main targets are the subthalamic nucleus (STN) and the globus pallidus internus (GPi), although it has not been established whether stimulation at one target is

Multicenter study on deep brain stimulat
✍ Marwan I. Hariz; Stig Rehncrona; Niall P. Quinn; Johannes D. Speelman; Carin Wen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract Ongoing adverse events (AEs) at 4‐years postsurgery in 69 patients with advanced Parkinson′s disease (PD) who received deep brain stimulation (DBS) of the subthalamic nucleus (STN) (n = 49) or the internal globus pallidus (GPi) (n = 20), in the framework of a subset of eight centers of